Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
45,168,309
-
Share change
-
-1,457,741
-
Total reported value
-
$606,022,346
-
Put/Call ratio
-
211%
-
Price per share
-
$13.42
-
Number of holders
-
115
-
Value change
-
-$19,006,942
-
Number of buys
-
56
-
Number of sells
-
48
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q3 2014
As of 30 Sep 2014,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,168,309 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, FMR LLC, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, BB Biotech AG, BlackRock Fund Advisors, WELLINGTON MANAGEMENT CO LLP, State Street Corp, and Point72 Asset Management, L.P..
This page lists
115
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.